RSV Vaccine Study

Respiratory syncytial virus (RSV) is a leading cause of respiratory illness in adults (second to the flu) with no specific prevention and treatment options. This trial is researching a vaccine that could help protect those with the greatest risk of severe illness and complications from RSV. This is a placebo based study.